Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of two amino acids, L-ornithine and L-aspartate, used in the management of hyperammonemia associated with liver dysfunction. It is believed to work by stimulating the urea cycle and promoting the detoxification of ammonia in the liver and peripheral tissues.
## Primary Indications
* **Hepatic Encephalopathy:** Treatment of overt hepatic encephalopathy (HE) in patients with cirrhosis.
## Adult Dosing
* **Initial Dose:** 10g to 20g intravenously (IV) daily.
* **Maintenance Dose:** Dosing varies and is often guided by clinical response and ammonia levels. A common regimen involves dividing the daily dose into 2-3 infusions.
* **Maximum Daily Dose:** Typically not to exceed 40g per day. Specific protocols may vary.
## Pediatric Dosing
Pediatric dosing is not well-established and should be determined by a specialist based on the individual child's condition, weight, and severity of hyperammonemia.
## Dose Adjustments
* **Renal Impairment:** Use with caution. No specific dose adjustment guidelines are widely available, but reduced doses may be considered due to potential accumulation. Monitor ammonia levels closely.
* **Hepatic Impairment:** The drug is indicated for patients with hepatic impairment; however, efficacy and safety may be influenced by the severity of liver disease.
## Contraindications
* Severe renal failure (creatinine clearance < 30 mL/min).
* Known hypersensitivity to L-ornithine or L-aspartate.
## Adverse Effects
* Nausea
* Vomiting
* Abdominal discomfort
* Diarrhea
* Flushing
* Rarely, allergic reactions.
## Key Drug Interactions
No significant drug interactions have been widely reported. However, caution should be exercised when co-administering with other medications affecting ammonia metabolism or renal function.
## Monitoring
* **Ammonia levels:** Monitor serum ammonia levels regularly to assess efficacy and guide dosing.
* **Renal function:** Monitor serum creatinine and BUN, especially in patients with pre-existing renal compromise.
* **Clinical status:** Assess for improvement in neurological symptoms of hepatic encephalopathy.
## Clinical Pearls
* Hepamerz is administered intravenously, typically as a continuous infusion or divided doses.
* The product is available as a solution for infusion, often in concentrations of 5g/10mL or 10g/20mL.
* Proper dilution and administration rate are crucial to minimize adverse effects like flushing.
***
**Disclaimer:** This information is intended for clinical use and does not replace a comprehensive review of the most current prescribing information, institutional protocols, or consultation with a medical professional. Always verify current dosing, indications, and safety information with the official drug product labeling and relevant clinical guidelines.
